2 results
Approved WMOCompleted
To investigate trastuzmab-paclitaxel in EGFR-mutated NSCLC patients who have overexpression of HER2 and who have progressed on standard TKI-treatment
Approved WMOCompleted
to assess patient's overall preference for the two inhaler devices in COPD patients after 2 weeks of dialy practice.